Skip to main content

Advertisement

Table 2 Follow-up periods and clinical outcomes post-intravitreal gentamicin injections

From: Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results.

Minimum follow-up period Controlled ERU (no recurrent or persistent inflammation, independent of complications) Average follow-up period (days) Standard deviation (± days) Range (days)
30 days 59/86 (68.6%) eyes 52/59 eyes 88.1% 238 190 30–780
3 month 43/86 (50.0%) eyes 36/43 eyes 83.7% 313 175 93–780
5 month 34/86 (39.5%) eyes 27/34 eyes 79.4% 359 164 153–780
7 month 24/86 (27.9%) eyes 20/24 83.3% 407 170 213–780
1 year 12/86 (14.0%) eyes 9/12 eyes 75% 541 137 365–780